Diasorin SpA (MIL:DIA) Accounts Payable & Accrued Expense : €194 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Accounts Payable & Accrued Expense?

Diasorin SpA's quarterly accounts payable & accrued expense stayed the same from Jun. 2023 (€0 Mil) to Sep. 2023 (€0 Mil) but then increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€194 Mil).

Diasorin SpA's annual accounts payable & accrued expense increased from Dec. 2021 (€179 Mil) to Dec. 2022 (€206 Mil) but then declined from Dec. 2022 (€206 Mil) to Dec. 2023 (€194 Mil).

Diasorin SpA Accounts Payable & Accrued Expense Historical Data

The historical data trend for Diasorin SpA's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Accounts Payable & Accrued Expense Chart

Diasorin SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

115.40

153.25

178.98

205.62

193.52

Diasorin SpA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															205.62	-	-	-	193.52

Diasorin SpA Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Diasorin SpA (MIL:DIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (MIL:DIA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

DSRLF:USA 0GZX:UK 34D:Germany

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.